Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL225253 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL1506911 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL9026558 | 0.88 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL2065111 | 0.88 | — | — | |
| Sulfuric Acid SCHEMBL2813617 | 0.88 | — | — | |
| Sulfuric Acid SCHEMBL9903424 | 0.88 | — | — | |
| Sulfuric Acid SCHEMBL9180031 | 0.88 | — | — | |
| Sulfuric Acid SCHEMBL9903427 | 0.88 | — | — | |
| Sulfuric Acid SCHEMBL10627306 | 0.88 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL28767776 | 0.88 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12187665-B2 | Crosslinking component for binder resins | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2025-01-07 | — | — | US | disclosed |
| US-20190337890-A1 | CROSSLINKING COMPONENT FOR BINDER RESINS | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2019-11-07 | — | — | US | disclosed |
| CN-106147565-A | The method forming the layer of electrophoretic painting compositions on electrophoretic painting compositions, its linked and substrate surface | 涂料外国IP有限公司 | 2016-11-23 | — | — | CN | disclosed |
| US-20160177022-A1 | CROSSLINKING COMPONENTS FOR ELECTROCOAT COMPOSITIONS, ELECTROCOAT COMPOSITIONS, AND PROCESSES FOR FORMING A LAYER OF AN ELECTROCOAT COMPOSITION ON A SURFACE OF A SUBSTRATE | AXALTA COATING SYSTEMS IP CO., LLC. | 2016-06-23 | — | — | US | disclosed |
| US-9102784-B2 | Acrylic anticrater additive for electrocoats | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2015-08-11 | — | — | US | disclosed |
| EP-1874982-B1 | METHOD FOR ELECTRODEPOSITION OF BRONZES | ENTHONE (US) | 2014-05-07 | — | — | EP | disclosed |
| US-20130075269-A1 | ACRYLIC ANTICRATER ADDITIVE FOR ELECTROCOATS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-28 | — | — | US | disclosed |
| EP-1874982-A1 | METHOD FOR ELECTRODEPOSITION OF BRONZES | Enthone, Inc. (US) | 2008-01-09 | — | — | EP | disclosed |
| US-20060260948-A2 | METHOD FOR ELECTRODEPOSITION OF BRONZES | ENTHONE INC. (US) | 2006-11-23 | — | — | US | disclosed |
| WO-2006113473-A1 | METHOD FOR ELECTRODEPOSITION OF BRONZES | ENTHONE INC. (US) | 2006-10-26 | — | — | WO | disclosed |
| US-20060137991-A1 | Method for bronze galvanic coating | ENTHONE INC (US) | 2006-06-29 | — | — | US | disclosed |
| US-20050263403-A1 | Method for electrodeposition of bronzes | ENTHONE INC. (US) | 2005-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12187665-B2 | Crosslinking component for binder resins | MACF1, INO80C, SMC4 | MEN1 2720/4885ALDH1A1 1351/4885TSHR 4878/4885 |
| US-20190337890-A1 | CROSSLINKING COMPONENT FOR BINDER RESINS | MACF1, INO80C, SMC4 | MEN1 2720/4885ALDH1A1 1351/4885TSHR 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.